28 Jun 2019 | News
The United States Patent and Trademark Office recently issued a notice of allowance for US patent application number 15/568,655 covering Technophage’s TZ-113 project. TZ-113 is a repurposing project for Parkinson’s patients targeting levodopa induced...
6 Mai 2019 | News
TechnoPhage’s CEO Miguel Garcia will attend the 11th Annual International Partnering Conference ChinaBio® Partnering Forum on May 8-9 in Shangai, China. If you wish to meet us at the conference feel free to contact us to info@technophage.pt to schedule a...
20 Mar 2019 | News
Labiotech.eu highlighted TechnoPhage as one of the top 15 biotech companies in Portugal. Click here to read the article.
19 Mar 2019 | News
Our Head of Infection, Clara Leandro, will attend the 1st Bacteriophage Therapy Summit in Boston between 25 and 27 of March. She will be one of the experts that will discuss how bacteriophage therapy can quickly become a reality for patients who are in need of...
16 Jan 2019 | News
PRESS RELEASE Ontem, dia 15 de janeiro de 2019, foi assinada a constituição da Associação, VectorB2B – Drug Developing – Associação para Investigação em Biotecnologia. O Vector B2B resultou da iniciativa partilhada de sete entidades, o Laboratório Medinfar, S.A., a...
5 Jun 2018 | News
Technophage was present at the 3rd edition of the “Innovation Sessions” event held in Brussels on 4 June 2018 at the European Economic and Social Council. This edition of the event was dedicated to the theme “Healthcare Systems and Future...
